We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Review
Macroencapsulated Pig Islets Correct Induced Diabetes in Primates up to 6 Months.
A bioartificial pancreas, in which islets of Langerhans are encapsulated within a semipermeable membrane, may be an alternative therapeutic device for diabetic patients. It may constitute another safe and simple method of transplanting islets without the need for immunosuppressive therapy. Since the semipermeable membrane protects the islets from the host immune system, the islets are likely to survive and release insulin for a long period of time, thereby controlling glucose metabolism in the absence of immunosuppressive medication. Recent data using macroencapsulation of pig islets in primate seems encouraging. In fact, a "mono/bilayer" configuration of macroencapsulated pig islets implanted subcutaneously has been found to significantly improve diabetes control in primates for 6 months without any immunosuppression.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app